183 related articles for article (PubMed ID: 27345793)
21. Generation of human iPS cell line CTL07-II from human fibroblasts, under defined and xeno-free conditions.
Kele M; Day K; Rönnholm H; Schuster J; Dahl N; Falk A
Stem Cell Res; 2016 Nov; 17(3):474-478. PubMed ID: 27789397
[TBL] [Abstract][Full Text] [Related]
22. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
[TBL] [Abstract][Full Text] [Related]
23. Microglial signalling pathway deficits associated with the patient derived R47H TREM2 variants linked to AD indicate inability to activate inflammasome.
Cosker K; Mallach A; Limaye J; Piers TM; Staddon J; Neame SJ; Hardy J; Pocock JM
Sci Rep; 2021 Jun; 11(1):13316. PubMed ID: 34172778
[TBL] [Abstract][Full Text] [Related]
24. Generation of human control iPS cell line CHOPWT10 from healthy adult peripheral blood mononuclear cells.
Maguire JA; Gagne AL; Jobaliya CD; Gandre-Babbe S; Gadue P; French DL
Stem Cell Res; 2016 Mar; 16(2):338-41. PubMed ID: 27345999
[TBL] [Abstract][Full Text] [Related]
25. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
[TBL] [Abstract][Full Text] [Related]
26. Establishment of SPAST mutant induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia (HSP) patient.
Hauser S; Erzler M; Theurer Y; Schuster S; Schüle R; Schöls L
Stem Cell Res; 2016 Nov; 17(3):485-488. PubMed ID: 27789400
[TBL] [Abstract][Full Text] [Related]
27. Characterization of dermal fibroblast-derived iPSCs from a patient with high grade steatosis.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):568-571. PubMed ID: 27789412
[TBL] [Abstract][Full Text] [Related]
28. Characterization of iPSCs derived from dermal fibroblasts from a healthy 19year old female.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):597-599. PubMed ID: 27934589
[TBL] [Abstract][Full Text] [Related]
29. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
Liu S; Ye Z; Gao Y; He C; Williams DW; Moliterno A; Spivak J; Huang H; Cheng L
Stem Cell Res; 2017 Jan; 18():57-59. PubMed ID: 28395806
[TBL] [Abstract][Full Text] [Related]
30. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.
Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D
Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626
[TBL] [Abstract][Full Text] [Related]
31. Generation of a human iPSC line from a patient with a defect of intergenomic communication.
Zurita F; Galera T; González-Páramos C; Moreno-Izquierdo A; Schneiderat P; Fraga MF; Fernández AF; Garesse R; Gallardo ME
Stem Cell Res; 2016 Jan; 16(1):120-3. PubMed ID: 27345795
[TBL] [Abstract][Full Text] [Related]
32. IPSC-Derived Neuronal Cultures Carrying the Alzheimer's Disease Associated
Martins S; Müller-Schiffmann A; Erichsen L; Bohndorf M; Wruck W; Sleegers K; Van Broeckhoven C; Korth C; Adjaye J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630447
[TBL] [Abstract][Full Text] [Related]
33. Generation of induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM).
Xiong K; Zhou Y; Hyttel P; Bolund L; Freude KK; Luo Y
Stem Cell Res; 2016 Nov; 17(3):665-669. PubMed ID: 27934604
[TBL] [Abstract][Full Text] [Related]
34. Derivation of the human induced pluripotent stem cell line MUi017-A from a patient with homozygous Hemoglobin Constant Spring.
Wongkummool W; Maneepitasut W; Munkongdee T; Tong-Ngam P; Tangprasittipap A; Svasti S; Kitiyanant N; Paiboonsukwong K; Fucharoen S; Tubsuwan A
Stem Cell Res; 2017 Apr; 20():84-87. PubMed ID: 28395746
[TBL] [Abstract][Full Text] [Related]
35. Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease.
Zhang S; Lv Z; Zhang S; Liu L; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():34-36. PubMed ID: 28413002
[TBL] [Abstract][Full Text] [Related]
36. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman.
Tangprasittipap A; Jittorntrum B; Wongkummool W; Kitiyanant N; Tubsuwan A
Stem Cell Res; 2017 Apr; 20():91-93. PubMed ID: 28395748
[TBL] [Abstract][Full Text] [Related]
37. Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene.
Ross SB; Fraser ST; Nowak N; Semsarian C
Stem Cell Res; 2017 Apr; 20():88-90. PubMed ID: 28395747
[TBL] [Abstract][Full Text] [Related]
38. Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A).
Graffmann N; Martins S; Ljubikj T; Matte JC; Bohndorf M; Wruck W; Adjaye J
Stem Cell Res; 2021 Mar; 51():102167. PubMed ID: 33485181
[TBL] [Abstract][Full Text] [Related]
39. A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC-derived microglia.
Piers TM; Cosker K; Mallach A; Johnson GT; Guerreiro R; Hardy J; Pocock JM
FASEB J; 2020 Feb; 34(2):2436-2450. PubMed ID: 31907987
[TBL] [Abstract][Full Text] [Related]
40. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
